tirzepatide single dose pen Eli Lilly launches Zepbound obesity drug with one month of doses It’s also approved to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound (Tirzepatide) Weight Loss Pen
Pay in 4 interest-free payments of $5.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24



























